Article

ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin

Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo